BackAEON Biopharma Overview

AEON Biopharma Accounts Payable

Track AEON Biopharma's accounts payable ($1.5M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Accounts Payable
$1.48M
↓ 39.23% YoYΔ $-956000.00 vs prior year quarter

Peer average

Loading

AEON Biopharma Accounts Payable History

Loading

AEON Biopharma vs. peers: Accounts Payable Comparison

Loading

AEON Biopharma Accounts Payable Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

AEON Biopharma (AEON) FAQ

As of the most recent data (March 2026), AEON shows a accounts payable of $1.5M. That compares with $2.4M in the prior-year period — down 39.2% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AEON's accounts payable is now $1.5M (was $2.4M) — a 39.2% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether AEON Biopharma is outperforming or lagging.

Tracking AEON's accounts payable over time shows whether AEON Biopharma is scaling, shrinking, or reshaping that part of the business. The current reading is $1.5M That compares with $2.4M in the prior-year period — down 39.2% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this accounts payable page, Stockcircle has AEON Biopharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect accounts payable (currently $1.5M) with ownership activity and broader fundamentals.